
メタグロスδ-デルタ種 (Unlimited Holofoil)
Metagross δ
ホロンの研究塔
Holon Research Tower · #40
Overview
Legality, special rules, and flavor text
Format legality
- StandardNot Legal
- UnlimitedLegal
- ExpandedNot Legal
- Gym Leader ChallengeNot Legal
Card details
Printing, type line, and catalog data
Identity & printing
- Card ID
- pcg6_ja-40--unlimitedHolofoil
- Name
- メタグロスδ-デルタ種 (Unlimited Holofoil)
Metagross δ - Number
- 40
- Printed number
- 040/086
- Rarity
- レアホロ
Rare Holo - Rarity code
- ★H
- Variant
- Unlimited Holofoil
Type line & stats
- Supertype
- ポケモン
Pokémon - Subtypes
- 2進化
Stage 2, Delta Species - Types
- 雷
Lightning, 鋼
Metal - HP
- 100
Set, artist & references
- Retreat cost
- 1
Colorless - Artist
- Masakazu Fukuda
- Language
- Japanese
- Set name
- ホロンの研究塔
Holon Research Tower - Game name
- Pokémon Japan
Battle
Abilities, attacks, weakness & resistance
Abilities
- ポケパワー: Delta Control
Once during your turn (before your attack), you may look at the top 4 cards of your deck, choose 1 of them, and put it into your hand. Put the 3 other cards on the bottom of your deck in any order. This power can't be used if Metagross is affected by a Special Condition.
Attacks
- Crush and Burn30+Cost: 2
You may discard as many Energy cards as you like attached to your Pokémon in play. If you do, this attack does 30 damage plus 20 more damage for each Energy card you discarded.
Weaknesses
- 炎
Fire ×2
Resistances
- 草
Grass -30
eBay market prices
Sold and listed medians — tap a grade for comps
Prices last updated Mar 20, 2026, 3:41 PM
More conditions (eBay)
Add LP / MP / HP / DMG or a slab grade (PSA 8, ACE 9, BGS 9.5, …). Everyone sees the same prices; scheduled refreshes include these variants.
Listed on marketplace
Vendors currently listing this card/product on our marketplace. Click through to view or purchase (purchase flow coming soon).
No marketplace listings for this card right now.
More in this set
Other cards from Holon Research Tower
Comments
Share your thoughts on this card — condition, value, pull rates, etc.
to comment.
No comments yet. Be the first to share your thoughts.











